Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06689761

Influence of Specific Collagen Peptides on Training-Induced Metabolic and Biomechanical Adaptations of Skeletal Muscle

This study investigates whether taking daily collagen peptides, combined with long-term endurance or concurrent training can enhance running economy through muscle and/or tendon adaptations.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year–40 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Centre for Sport Science and University Sports, Department of Sport and Human Movement Science

Vienna, State of Vienna, 1150, Austria

About this study

An adequate and high-quality intake of proteins and amino acids is crucial for synthesizing the body's own connective tissue-like structures, such as muscles, tendons, ligaments, and bones. Various metabolic and hormonal processes are regulated or influenced by proteins. It is undisputed that measurable improvements are only possible through the combination of training and protein intake. Simply increasing protein intake without physical activity cannot be expected to result in structural or metabolic adaptations.

In recent years, interest in regular collagen intake in sports nutrition, particularly in connection with moderate to intense physical activity, has increased. Since collagen and its peptides are primarily found in force-transmitting structures such as tendons, studies have been conducted to examine how tendons adapt to collagen peptide supplementation. Studies by Jerger et al. (2022 & 2023) have shown that both the patellar and Achilles tendons adapt to collagen supplementation, as evidenced by an increased cross-sectional area compared to a non-caloric placebo. This increase allows tendons to withstand greater forces, making them more resilient and thus playing an important role in injury prevention. These results were achieved with a dose of 5g of collagen combined with three months of strength training.

Additionally, multi-month collagen peptide supplementation combined with concurrent training (strength and endurance training in one session) led to improved endurance performance. Both running distance and speed at the aerobic and anaerobic thresholds significantly increased compared to a placebo group with a daily intake of 15g of collagen over three months (Jerger et al. 2023, Jendricke et al. 2020).

Based on these results, the question arises as to whether regularly supplemented collagen peptides, combined with pure endurance training, lead to similar metabolic and/or tendon-specific adaptations. Therefore, the aim of this proposed study is to investigate both metabolic and specific (morphological, mechanical, and material) properties of the Achilles and patellar tendons to determine the mechanism through which the so-called "running economy" develops in connection with collagen peptides. The results will be compared to those of concurrent training, which has already shown metabolic adaptations as described above.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male gender Age 18-40 years No subjective symptoms during physical exertion BMI of 18.5 to 26 Stable weight and dietary habits No extensive strength/endurance training (less than 3 hours per week) No contraindications to physical exertion according to ACSM guidelines No contraindications to supplemental nutrition or ergogenic supplements

Exclusion criteria

Contraindications to physical activity (e.g., chronic heart disease, arrhythmia, heart valve disease, arthritis, etc.; general exclusion criteria according to ACSM 2009; intolerance/aversion to animal protein) Arterial hypertension (systolic BP > 200 mmHg and/or diastolic BP > 105 mmHg) at rest Insulin-dependent diabetes mellitus (IDDM) Liver and/or kidney disease that excludes a high protein load

Treatment and study plan

ColCT

Dietary Supplement

Dietary Supplement: Collagen Participants ingest 15 grams of specific collagen peptides daily

ColET

Dietary Supplement

Dietary Supplement: Collagen Participants ingest 15 grams of specific collagen peptides daily

PlaCT

Dietary Supplement

Dietary Supplement: Placebo. Participants ingest 15 grams of placebo daily

PlaET

Dietary Supplement

Dietary Supplement: Placebo. Participants ingest 15 grams of placebo daily

Primary outcomes

  1. One-hour time trial performance

    Time frame: Baseline and after 12 weeks

    Participants run an hour on the track outside as far as possible

  2. Achilles tendon cross sectional-area

    Time frame: Baseline and after 12 weeks

    Ultrasound

  3. Achilles and Patellar tendon Stiffness

    Time frame: Baseline and after 12 weeks

    Ultrasound + isokinetic dynamometer

  4. VO2max

    Time frame: Baseline and after 12 weeks

    treadmill with spirometry

Secondary outcomes

  1. Body composition

    Time frame: Baseline and after 12 weeks

    Fat mass, fat-free mass, extracellular mass, body cell mass, skeletal muscle mass. Measured by bioelectrical impedance analysis

  2. Achilles tendon stress, strain, Young's modulus

    Time frame: Baseline and after 12 weeks

    Ultrasound + isokinetic dynamometer

  3. Patellar tendon strain

    Time frame: Baseline and after 12 weeks

    Ultrasound + isokinetic dynamometer

  4. RER, VT1, VT2, LTP1, LTP2, HFrel., FATox.

    Time frame: Baseline and after 12 weeks

    treadmill with spirometry and blood (lactate) collection.

  5. Achilles tendon echointensity

    Time frame: Baseline and after 12 weeks

    Ultrasound

Other outcomes

  1. Energy and macronutrient intake

    Time frame: Baseline and after 12 weeks

    kcal, protein, carbs, fat. 2x 3 day questionnaire (start and end of study)

Sponsors and collaborators

Lead sponsor

University of Vienna

Other

Collaborators

  • Collagen Research Institute

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Nov 14, 2024
Registry last updated
Nov 14, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.